Parkinson's disease UPDATE || Public Health Genomics Knowledge Base (v1.0) || July 7-14, 2016

Public Health Genomics Knowledge Base (v1.0)



July 7-14, 2016 


Last Updated: Jul 07, 2016

• ETHICAL AND GENETIC ASPECTS REGARDING PRESYMPTOMATIC TESTING FOR NEURODEGENERATIVE DISEASES.
  Rev Med Chir Soc Med Nat Iasi. 2016 Jan-Mar;120(1):15-22.
• Characteristics of Nonmotor Symptoms in Progressive Supranuclear Palsy.
  Ou Ruwei, et al. Parkinson's disease 2016 0 9730319
• Variants in ACPP are associated with cerebrospinal fluid Prostatic Acid Phosphatase levels.
  Staley Lyndsay A, et al. BMC genomics 2016 0 439
• Association of AKT1 Gene Polymorphisms with Sporadic Parkinson's disease in Chinese Han Population.
  Li Xiao-Yuan, et al. Neuroscience letters 2016 6
• SLC6A3 rs28363170 and rs3836790 variants in Han Chinese patients with sporadic Parkinson's disease.
  Lu Qian, et al. Neuroscience letters 2016 6
• Prodromal Clinical Markers of Parkinson disease in Gaucher Disease Individuals.
  Gatto Emilia M, et al. European neurology 2016 6 (1-2) 19-21
• Vitamin D receptor polymorphisms and Parkinson's disease in a Korean population: Revisited.
  Kang Seo Young, et al. Neuroscience letters 2016 6
• Salivary total ?-synuclein, oligomeric ?-synuclein and SNCA variants in Parkinson's disease patients.
  Kang Wenyan, et al. Scientific reports 2016 0 28143
• Effect of a Leucine-rich Repeat Kinase 2 Variant on Motor and Non-motor Symptoms in Chinese Parkinson's Disease Patients.
  Sun Qian, et al. Aging and disease 2016 5 (3) 230-6
• The rs3857059 variant of the SNCA gene is associated with Parkinson's disease in Mexican Mestizos.
  García S, et al. Arquivos de neuro-psiquiatria 2016 6 (6) 445-9
• Dopamine D3 receptor Ser9Gly variant is associated with impulse control disorders in Parkinson's disease patients.
  Krishnamoorthy Soumya, et al. Parkinsonism & related disorders 2016 6
• Apolipoprotein E ?4 does not affect cognitive performance in patients with Parkinson's disease.
  Mengel David, et al. Parkinsonism & related disorders 2016 4
• The NFE2L2 rs35652124 polymorphism and the risk of Parkinson's disease: a systematic review and meta-analysis.
  Zhu Mengru, et al. Neuroreport 2016 6
• Genetic Mutation Analysis of Parkinson's Disease Patients Using Multigene Next-Generation Sequencing Panels.
  Gorostidi Ana, et al. Molecular diagnosis & therapy 2016 6
• Presence of cerebral amyloid modulates phenotype and pattern of neurodegeneration in early Parkinson's disease.
  McMillan Corey T, et al. Journal of neurology, neurosurgery, and psychiatry 2016 6

• CDC Information (0)
• CDC-Authored Pub (2)

• Human (6)
• Pathogen (2)

• Human (1735)
• Pathogen (0)

• Human (8)
• Pathogen (0)

Relevant Resources

• Cancer Genomics and Epidemiology Navigator (CGEN)
• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB